Acorah Software Products - Accounts Production 16.1.300 false true true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 14038173 Mr Malcolm Burenstam Linder Mr Hans Strom Goodwille Limited Alva Labs AB Kivra: 559103-8178, Stockholm, Sweden true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14038173 2023-12-31 14038173 2024-12-31 14038173 2024-01-01 2024-12-31 14038173 frs-core:CurrentFinancialInstruments 2024-12-31 14038173 frs-core:ShareCapital 2024-12-31 14038173 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 14038173 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14038173 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 14038173 frs-bus:SmallEntities 2024-01-01 2024-12-31 14038173 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 14038173 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 14038173 1 2024-01-01 2024-12-31 14038173 frs-bus:Director1 2024-01-01 2024-12-31 14038173 frs-bus:Director2 2024-01-01 2024-12-31 14038173 frs-bus:CompanySecretary1 2024-01-01 2024-12-31 14038173 frs-countries:EnglandWales 2024-01-01 2024-12-31 14038173 2022-12-31 14038173 2023-12-31 14038173 2023-01-01 2023-12-31 14038173 frs-core:CurrentFinancialInstruments 2023-12-31 14038173 frs-core:ShareCapital 2023-12-31 14038173 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 14038173
Alva Labs International Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Goodwille Limited
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 14038173
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 12,008 21,049
Cash at bank and in hand - 937
12,008 21,986
Creditors: Amounts Falling Due Within One Year 5 (163 ) (4,648 )
NET CURRENT ASSETS (LIABILITIES) 11,845 17,338
TOTAL ASSETS LESS CURRENT LIABILITIES 11,845 17,338
NET ASSETS 11,845 17,338
CAPITAL AND RESERVES
Called up share capital 6 300 300
Profit and Loss Account 11,545 17,038
SHAREHOLDERS' FUNDS 11,845 17,338
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Malcolm Burenstam Linder
Director
04/08/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Alva Labs International Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14038173 . The registered office is 1 Chapel Street, Warwick, CV34 4HL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Financial Instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like other debtors and creditors, loans from related parties and investments in non-puttable ordinary shares.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
2.6. Debtors
Basic financial assets, including other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
2.7. Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
2.8. Creditors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
2.9. Share Capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Page 2
Page 3
3. Average Number of Employees
Average number of employees, including directors, during the year was as follows: NIL (2023: 2)
- 2
4. Debtors
2024 2023
£ £
Due within one year
Corporation tax recoverable assets 1,472 -
VAT - 90
Amounts owed by group undertakings 10,536 20,959
12,008 21,049
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 163 69
Corporation tax - 3,379
Accruals and deferred income - 1,200
163 4,648
6. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 300 300
7. Dividends
No dividends were proposed or paid during the current or prior year. 
8. Related Party Transactions
The company is a wholly owned subsidiary member of its group and has therefore taken advantage of the provisions of Section 33. 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” not to disclose transactions with entities that are wholly owned members of the group.
9. Ultimate Parent Undertaking and Controlling Party
The company's immediate and ultimate parent undertaking is Alva Labs AB . Alva Labs AB was incorporated in Sweden. Copies of the group accounts may be obtained from the secretary, Kivra: 559103-8178, Stockholm, Sweden . The ultimate controlling party is Alva Labs AB who controls 100% of the shares of Alva Labs International Limited .
10. Audit Information
The auditor's report on the accounts of Alva Labs International Limited for the year ended 31 December 2024 was unqualified.
The auditor's report was signed by Statutory Auditor.
Page 3